COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure
Status:
Completed
Trial end date:
2021-05-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of LCZ696 vs. Enalapril on improvement
in erectile function and ability in male patients with chronic heart failure with reduced
ejection fraction and erectile dysfunction
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Enalapril Enalaprilat LCZ 696 Sacubitril and valsartan sodium hydrate drug combination Valsartan